Astrid Kramer

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness.

CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness.

Journal: Therapeutic advances in medical oncology

Published: July 08, 2025

Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology.

Towards Recommendations for Cost-Effectiveness Analysis of Predictive, Prognostic, and Serial Biomarker Tests in Oncology.

Journal: PharmacoEconomics

Published: January 19, 2025

Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer.

Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer.

Journal: Therapeutic advances in medical oncology

Published: January 04, 2024

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

Journal: Molecular oncology

Published: July 07, 2023

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

Journal: Cancers

Published: February 22, 2022

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

Journal: The Journal of molecular diagnostics : JMD

Published: December 24, 2021

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.

Image-guided navigation for locally advanced primary and locally recurrent rectal cancer: evaluation of its early cost-effectiveness.

Journal: BMC cancer

Published: September 30, 2020

Ras moves to stay in place.

Ras moves to stay in place.

Journal: Trends in cell biology

Published: December 22, 2014

Showing 1-8 of 8

Last Updated: 09/26/2026